The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
暂无分享,去创建一个
T. Zuberbier | G. Canonica | D. Larenas-Linnemann | D. Larenas-Linnemann | C. Bindslev‐Jensen | P. Schmid‐Grendelmeier | W. Aberer | J. Bernstein | G. Vena | M. Gonçalo | A. Giménez-Arnau | T. Craig | M. Sanchez‐Borges | J. Hébert | C. Vestergaard | Z. Brzoza | A. Nast | C. Dressler | C. Katelaris | S. Rosumeck | R. Werner | A. Kaplan | M. Maurer | M. Magerl | P. Staubach | B. Wedi | M. Maurer | M. Church | E. Nettis | M. Hide | P. Mathelier-Fusade | B. Ballmer-Weber | R. Asero | A. Kapp | M. Metz | K. Godse | L. Ensina | S. Saini | C. Grattan | K. Kulthanan | E. Toubi | A. H. Abdul Latiff | A. Latiff | D. Baker | G. Sussman | T. Leslie | R. Bedrikow | R. Meshkova | J. Hebert | E. Kocatürk | H. Oude-Elberink | A. Giménez-Arnau | I. Danilycheva | Z. Zhao | E. Toubi | A. Kapp | R. Buense Bedrikow | Z. Zhao | G. W. Canonica | Gino A. Vena | Alexander Nast | G. A. Vena | A. Nast | M. Sánchez-Borges | D. Larenas‐Linnemann
[1] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.
[2] T. Zuberbier,et al. Executive summary of the methods report for ‘The EAACI/GA2LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update’ , 2018, Allergy.
[3] R. Asero. Faculty of 1000 evaluation for Omalizumab treatment in chronic inducible urticaria: A systematic review of published evidence. , 2018 .
[4] M. Maurer,et al. Comparison and interpretability of the available urticaria activity scores , 2018, Allergy.
[5] M. Maurer,et al. Chronic Urticaria in Children: Still Itching for Insight. , 2017, JAMA dermatology.
[6] T. Zuberbier,et al. Responsiveness and minimal important difference of the urticaria control test , 2017, The Journal of allergy and clinical immunology.
[7] T. Casale,et al. The XTEND‐CIU study: Long‐term use of omalizumab in chronic idiopathic urticaria , 2017, The Journal of allergy and clinical immunology.
[8] M. Maurer,et al. Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review. , 2017, The journal of allergy and clinical immunology. In practice.
[9] S. Zimmer,et al. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial. , 2017, The Journal of allergy and clinical immunology.
[10] T. Jakob,et al. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. , 2017, The Journal of allergy and clinical immunology.
[11] A. Finlay,et al. Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[12] A. Marzano,et al. Chronic urticaria: a focus on pathogenesis , 2017, F1000Research.
[13] F. Bérard,et al. The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU , 2017, Allergy.
[14] O. Schmetzer,et al. Autoimmune chronic spontaneous urticaria: What we know and what we do not know , 2017, The Journal of allergy and clinical immunology.
[15] K. Rutkowski,et al. How to manage chronic urticaria ‘beyond’ guidelines: a practical algorithm , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[16] M. Metz. Asthma-Medikament hilft auch bei Hauterkrankung , 2017, Aktuelle Dermatologie.
[17] T. Jakob,et al. H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] M. Labrador-Horrillo,et al. Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[19] Mitesh K. Patel,et al. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. , 2017, Allergy and asthma proceedings.
[20] L. Skov,et al. Treatment of Refractory Chronic Spontaneous Urticaria with Adalimumab. , 2017, Acta dermato-venereologica.
[21] P. Staubach,et al. A Popular myth – low‐histamine diet improves chronic spontaneous urticaria – fact or fiction? , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[22] T. Omachi,et al. Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria. , 2017, The Journal of investigative dermatology.
[23] Janko Brand,et al. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria. , 2017, The Journal of allergy and clinical immunology.
[24] S. Ferrucci,et al. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria , 2017, International Archives of Allergy and Immunology.
[25] F. Kianifard,et al. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[26] Young-Ho Jung,et al. Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children , 2017, Allergy, asthma & immunology research.
[27] M. Maurer,et al. Potential blood biomarkers in chronic spontaneous urticaria , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] F. Guillén-Grima,et al. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta‐analysis , 2016, The British journal of dermatology.
[29] C. Parisi,et al. Direct Medical Costs of Chronic Urticaria in a Private Health Organization of Buenos Aires, Argentina. , 2016, Value in health regional issues.
[30] E. Rahme,et al. Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity , 2016, International Archives of Allergy and Immunology.
[31] M. Maurer,et al. Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria. , 2016, The Journal of allergy and clinical immunology.
[32] E. Vezir,et al. Clinical and etiologic evaluation of the children with chronic urticaria. , 2016, Allergy and asthma proceedings.
[33] S. Ozen,et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) , 2016, Annals of the rheumatic diseases.
[34] J. Yélamos,et al. Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease , 2016, Immunity, inflammation and disease.
[35] M. Maurer,et al. Effect of omalizumab on angioedema in H1‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ACT, a randomized controlled trial , 2016, Allergy.
[36] P. Kuna,et al. Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[37] W. Forte,et al. A prospective ten-year follow-up of patients with chronic urticaria. , 2016, Allergologia et immunopathologia.
[38] Ling Meng,et al. Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials. , 2016, The Journal of allergy and clinical immunology.
[39] T. Zuberbier,et al. The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision , 2016, Allergy.
[40] M. Rajappa,et al. Association among stress, hypocortisolism, systemic inflammation, and disease severity in chronic urticaria. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[41] M. Maurer,et al. ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real‐life clinical practice , 2016, The British journal of dermatology.
[42] M. Maurer,et al. Chronic spontaneous urticaria and internal parasites – a systematic review , 2016, Allergy.
[43] L. Barkai,et al. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2–11 years , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[44] N. Kounis,et al. Exercise-induced urticaria, cholinergic urticaria, and Kounis syndrome , 2016, Journal of pharmacology & pharmacotherapeutics.
[45] A. Brennan,et al. Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria , 2015, PharmacoEconomics.
[46] B. Choi,et al. Basophil Markers for Identification and Activation in the Indirect Basophil Activation Test by Flow Cytometry for Diagnosis of Autoimmune Urticaria , 2015, Annals of laboratory medicine.
[47] A. Kirshenbaum,et al. Helicobacter pylori: A significant and treatable cause of chronic urticaria and angioedema , 2015, The Nurse practitioner.
[48] M. Magerl,et al. An improved Peltier effect‐based instrument for critical temperature threshold measurement in cold‐ and heat‐induced urticaria , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[49] N. Hunzelmann,et al. Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study , 2015, American Journal of Clinical Dermatology.
[50] M. Kowalski,et al. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. , 2015, The Journal of allergy and clinical immunology.
[51] M. Broder,et al. Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria , 2015, American Journal of Clinical Dermatology.
[52] M. Magerl,et al. Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism , 2015, Clinical and experimental dermatology.
[53] S. Ishaq,et al. Helicobacter pylori and gastric cancer: a state of the art review , 2015, Gastroenterology and hepatology from bed to bench.
[54] A. B. Kay,et al. Elevations in T‐helper‐2‐initiating cytokines (interleukin‐33, interleukin‐25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria , 2015, The British journal of dermatology.
[55] A. Giménez-Arnau,et al. Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study. , 2015, Acta dermato-venereologica.
[56] M. Cabana,et al. The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. , 2015, The Journal of allergy and clinical immunology.
[57] Misbah Ghazanfar,et al. Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies , 2015, Case reports in medicine.
[58] H. Kita,et al. Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin , 2014, The British journal of dermatology.
[59] M. Maurer,et al. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. , 2014, Journal of dermatological science.
[60] H. Kita,et al. Calcitonin gene‐related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[61] S. Spector,et al. Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study , 2014, The Journal of investigative dermatology.
[62] T. Zuberbier,et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. , 2014, Allergy.
[63] T. Zuberbier,et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.
[64] S. Gangemi,et al. Urticaria and bacterial infections. , 2014, Allergy and asthma proceedings.
[65] T. Casale,et al. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. , 2014, The Journal of allergy and clinical immunology.
[66] M. Maurer,et al. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. , 2014, JAMA dermatology.
[67] Simon Francis Thomsen,et al. TNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 Patients , 2013, Journal of allergy.
[68] P. Martus,et al. Development, validation, and initial results of the Angioedema Activity Score , 2013, Allergy.
[69] P. Kuna,et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. , 2013, The Journal of allergy and clinical immunology.
[70] M. Magerl,et al. A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism , 2013, Clinical and experimental dermatology.
[71] T. Zuberbier,et al. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. , 2013, Acta dermato-venereologica.
[72] T. Casale,et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.
[73] P. Schmid‐Grendelmeier,et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria , 2013, Allergy.
[74] R. Cecere,et al. Anisakis simplex Hypersensitivity Is Associated with Chronic Urticaria in Endemic Areas , 2012, International Archives of Allergy and Immunology.
[75] K. Iqbal,et al. A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria , 2012, Clinical and Translational Allergy.
[76] O. Kalayci,et al. Effects of low pseudoallergen diet on urticarial activity and leukotriene levels in chronic urticaria , 2012, Archives of Dermatological Research.
[77] S. Spector,et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. , 2011, The Journal of allergy and clinical immunology.
[78] T. Satoh,et al. Basophil recruitment and activation in inflammatory skin diseases , 2011, Allergy.
[79] K. Schäkel,et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. , 2011, The Journal of allergy and clinical immunology.
[80] J. Bousquet,et al. Recommendations for assessing patient‐reported outcomes and health‐related quality of life in patients with urticaria: a GA2LEN taskforce position paper , 2011, Allergy.
[81] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[82] Gordon H Guyatt,et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.
[83] M. Senda,et al. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio , 2011, Human psychopharmacology.
[84] J. Bousquet,et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.
[85] N. Papadopoulos,et al. Evidence for Clinical Safety, Efficacy, and Parent and Physician Perceptions of Levocetirizine for the Treatment of Children with Allergic Disease , 2011, International Archives of Allergy and Immunology.
[86] P. Stock,et al. Chronic spontaneous urticaria in children: Itching for insight , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[87] T. Zuberbier,et al. Antihistamine‐resistant urticaria factitia successfully treated with anti‐immunoglobulin E therapy , 2010, Allergy.
[88] T. Zuberbier,et al. Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria , 2010, International Archives of Allergy and Immunology.
[89] E. Compalati,et al. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system , 2010, Current opinion in allergy and clinical immunology.
[90] J. Bousquet,et al. Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.
[91] R. Asero,et al. Heparin and Tranexamic Acid Therapy May Be Effective in Treatment-Resistant Chronic Urticaria with Elevated D-Dimer: A Pilot Study , 2010, International Archives of Allergy and Immunology.
[92] P. Staubach,et al. Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[93] Todor A Popov,et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. , 2010, The Journal of allergy and clinical immunology.
[94] T. Zuberbier,et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria , 2010, The British journal of dermatology.
[95] C. Bindslev‐Jensen,et al. Efficacy of omalizumab in delayed pressure urticaria: a case report , 2010, Allergy.
[96] B. Wedi,et al. Effective treatment of refractory severe heat urticaria with omalizumab , 2009, Allergy.
[97] H. Schünemann,et al. EAACI/GA²LEN/EDF/WAO guideline: management of urticaria , 2009, Allergy.
[98] P. Schmid‐Grendelmeier,et al. EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria , 2009, Allergy.
[99] M. Maurer,et al. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo‐ controlled treatment with rupatadine 10 and 20 mg , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[100] M. Weinberger,et al. Experience with Cyclosporine in Children with Chronic Idiopathic Urticaria , 2009, Pediatric dermatology.
[101] P. Auquier,et al. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life , 2009, Allergy.
[102] T. Zuberbier,et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. , 2009, The Journal of allergy and clinical immunology.
[103] H. Laubach,et al. Incremental build‐up food challenge – a new diagnostic approach to evaluate pseudoallergic reactions in chronic urticaria: a pilot study , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[104] S. Saini,et al. New concepts in chronic urticaria. , 2008, Current opinion in immunology.
[105] G. Konstantinou,et al. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. , 2008, Journal of the American Academy of Dermatology.
[106] Christof Schaefer,et al. The safety of cetirizine during pregnancy. A prospective observational cohort study. , 2008, Reproductive toxicology.
[107] R. Hamilton,et al. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. , 2008, The Journal of investigative dermatology.
[108] T. Zuberbier,et al. How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.
[109] B. Engin,et al. Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial. , 2008, Acta dermato-venereologica.
[110] G. Viegi,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.
[111] T. Zuberbier,et al. Successful treatment of solar urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.
[112] T. Zuberbier,et al. Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapy , 2008, Allergy.
[113] T. Ilknur,et al. Candida spp. colonization and serum anticandidal antibody levels in patients with chronic urticaria , 2007, Clinical and experimental dermatology.
[114] E. Faria,et al. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. , 2007, European annals of allergy and clinical immunology.
[115] Samir K. Gupta,et al. Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adults. , 2007, British journal of clinical pharmacology.
[116] Samir K. Gupta,et al. Pharmacokinetics of desloratadine in children between 2 and 11 years of age. , 2007, British journal of clinical pharmacology.
[117] T. Zuberbier,et al. Urticaria: current opinions about etiology, diagnosis and therapy. , 2007, Acta dermato-venereologica.
[118] M. Maurer,et al. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. , 2007, The Journal of allergy and clinical immunology.
[119] M. Munday,et al. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506 , 2007, British journal of pharmacology.
[120] G. Vena,et al. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. , 2006, Journal of the American Academy of Dermatology.
[121] J. Boyce. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. , 2006, The Journal of allergy and clinical immunology.
[122] H. Schünemann,et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.
[123] E. Nettis,et al. Sodium benzoate‐induced repeated episodes of acute urticaria/angio‐oedema: randomized controlled trial , 2004, The British journal of dermatology.
[124] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[125] C. Bachert,et al. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis – a pooled analysis of three studies , 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[126] G. Dawn,et al. Effect of high‐dose intravenous immunoglobulin in delayed pressure urticaria , 2003, The British journal of dermatology.
[127] G. Canonica,et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy , 2003, Allergy.
[128] C. Grattan,et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[129] A. Kaplan. Clinical practice. Chronic urticaria and angioedema. , 2002, The New England journal of medicine.
[130] P. Seed,et al. Randomized double‐blind study of cyclosporin in chronic ‘idiopathic’ urticaria , 2000, The British journal of dermatology.
[131] S. Beissert,et al. UVA rush hardening for the treatment of solar urticaria. , 2000, Journal of the American Academy of Dermatology.
[132] P. Pigatto,et al. Chronic urticaria: a mystery , 2000, Allergy.
[133] M. Sticherling,et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. , 1999, The Journal of allergy and clinical immunology.
[134] Greaves. Urticaria — Clinical, Diagnostic and Therapeutic Aspects , 1998 .
[135] D. Schadendorf,et al. Differential Endothelial Adhesion Molecule Expression in Early and Late Whealing Reactions , 1998, International Archives of Allergy and Immunology.
[136] Winkelmann,et al. Intravenous immunoglobulin in autoimmune chronic urticaria , 1998, The British journal of dermatology.
[137] D. Schadendorf,et al. Enhanced P-selectin expression in chronic and dermographic urticaria. , 1997, International archives of allergy and immunology.
[138] M. Morgan,et al. The impact of chronic urticaria on the quality of life , 1997, The British journal of dermatology.
[139] T. Zuberbier,et al. Acute urticaria: clinical aspects and therapeutic responsiveness. , 1996, Acta dermato-venereologica.
[140] T. Zuberbier,et al. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. , 1995, Acta dermato-venereologica.
[141] D. Hunter,et al. Qualitative Research: Consensus methods for medical and health services research , 1995 .
[142] R. Barlow,et al. Plasmapheresis for severe, unremitting, chronic urticaria , 1992, The Lancet.
[143] V. Casolaro,et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. , 1992, The Journal of investigative dermatology.
[144] J. Toribio,et al. Incidence of Leukocytoclastic Vasculitis in Chronic Idiopathic Urticaria; Study of 100 Cases , 1989, The American Journal of dermatopathology.
[145] A. Black,et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine , 1989, The British journal of dermatology.
[146] J. Dover,et al. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients. , 1988, Journal of the American Academy of Dermatology.
[147] L. Juhlin. Recurrent urticaria: clinical investigation of 330 patients , 1981, The British journal of dermatology.
[148] H. Zachariae,et al. Oral Sodium Cromoglycate in Chronic Urticaria , 1980, Allergy.
[149] J. Prchal,et al. Aberrant expression of microRNA in polycythemia vera , 2008, Haematologica.
[150] G. Laurberg. Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study. , 1977, Acta dermato-venereologica.
[151] A. Kaplan,et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. , 1975, The Journal of allergy and clinical immunology.
[152] E. Ellis,et al. Treatment of cold urticaria with cyproheptadine. , 1971, The Journal of allergy and clinical immunology.
[153] T. Fujita,et al. [On the causes of urticaria]. , 1960, Hifuka no rinsho. Rinsho derma.
[154] Bernstein,et al. / GA 2 LEN / EDF / WAO guideline for the definition , classification , diagnosis and management of urticaria , 2018 .
[155] S. Gangemi,et al. Association between urticaria and virus infections: A systematic review. , 2016, Allergy and asthma proceedings.
[156] A. Giménez-Arnau,et al. Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria. , 2016, Acta dermato-venereologica.
[157] K. Gharib,et al. Helicobacter pylori Infection as a Risk Factor in Patients Suffering from Food Allergy and Urticaria. , 2016, The Egyptian journal of immunology.
[158] Chun-Ying Wu,et al. Cancer risk in patients with chronic urticaria: a population-based cohort study. , 2012, Archives of dermatology.
[159] R. Asero,et al. Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis. , 2010, Journal of investigational allergology & clinical immunology.
[160] G. Koren,et al. Risk of Hypospadias in Offspring of Women Using Loratadine during Pregnancy , 2008, Drug safety.
[161] K. Kontou-Fili,et al. Suppression of histamine-induced skin reactions by loratadine and cetirizine diHCl , 2004, European Journal of Clinical Pharmacology.
[162] C. Foti,et al. Acute allergic reactions to Anisakis simplex after ingestion of anchovies. , 2002, Acta dermato-venereologica.
[163] T. Zuberbier,et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. , 1996, Dermatology.
[164] S. Vieths,et al. 740 Characterization of naturally occuring pseudoallergens causing chronic urticaria , 1996 .
[165] M. Greaves. Chronic urticaria. , 1995, The New England journal of medicine.
[166] A. Ormerod,et al. Calcium antagonist in the treatment of symptomatic dermographism. Low-dose and high-dose studies with nifedipine. , 1988, Dermatologica.
[167] E. Kokkonen,et al. Ultraviolet light therapy in chronic urticaria. , 1985, Acta dermato-venereologica.